Drugs / G-CSF
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01723657 Background | Oct 2003 → Mar 2012 | acute myeloid leukemia | Spanish Cooperative Group for the Study and Treatment of Acute Leukemias and Myelodysplasias | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01723657 ↗ |
| Route | Subcutaneous | “with the addition of subcutaneous G-CSF from day 0 to the last day of chemotherapy.” NCT01723657 ↗ |